Torrent Pharmaceuticals Share Price

₹ 4,710.00

-₹28.50 (-0.6%)
1D
Last updated 05 Nov, 2026, 15:28 IST
NSE: TORNTPHARM
|
Pharmaceuticals

Torrent Pharmaceuticals Share Price Today

As of 6 Nov 2026, Torrent Pharmaceuticals share price is ₹4,710.00. The stock opened at ₹4,753.40, compared to its previous close of ₹4,738.50. During today's trading session, Torrent Pharmaceuticals share price moved in the range of ₹4,679.10 to ₹4,753.40, with an average price of ₹4,716.25 for the day. Looking at its last 52-week, the stock has touched a low of ₹3,532.60 and a high of ₹5,250.00. On the performance front, Torrent Pharmaceuticals share price has increased by 10.17% over the last six months and is up 31.75% on a year-on-year basis.

Share price over the last 1 day rose from 4700.00 to 4710.00, ranging between 4685.00 and 4742.90.
₹4,679.10
0.60% down today
₹4,753.40
1D LOW
1D HIGH

Torrent Pharmaceuticals Stock Insights

Latest Earning
Op Profit TrendUp by 0.55% QoQ
Latest Earning
Net Profit TrendUp by 11.88% YoY
Latest Earning
Revenue TrendUp by 1.22% QoQ
Stock Performance
OutperformingBeat Nifty by 8.71 % in last 6 month
Shareholding Pattern
DIIDII increased stake by 0.96%
Shareholding Pattern
FIIFII decreased stake by 4.18%
Technical Indicators
Volume SpikeVolume is 70.0% above 20-day average on 1 Day interval.
Torrent Pharmaceuticals stock performance
Open₹4,753.40
High₹4,753.40
Low₹4,679.10
Prev. close₹4,738.50
Torrent Pharmaceuticals trading activity
Volume5,08,335
Average traded price₹4,710.20
Last traded time03:28:27 05 Nov
Last traded quantity8,852
Circuit
L
H
₹4,570.10
₹4,852.70
52-week
L
H
₹3,532.60
₹5,250.00
Mkt Cap Cr
1,76,300.50
P/E
85.72
P/B
9.79
ROA
4.7%
ROE
11.42%
ROCE
11.37%
Quick Ratio
0.75
EV/EBITDA
33.85

Based on fundamentals, this stock's

Performance: 2 out of 5, Poor
Performance
Poor
Torrent Pharma. has underperformed the market
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Torrent Pharma. appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Torrent Pharma. revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,121.8938.794.779.61%13.79%18.65%2.3122.17
Divis Laboratories2,66,424.2791.0915.914.6%15.32%19.56%3.560.7
Laurus Labs1,24,601.4093.5220.5611.58%22.11%20.91%0.6852.92
Zydus Lifesciences1,18,702.9627.594.278.08%18.59%17.35%0.9116.36
Dr. Reddy's Laboratories1,14,518.1441.52.954.79%7.21%8.58%1.3519.27
Cipla1,12,471.7539.633.26.6%8.18%10.8%2.521.31
Mankind Pharma1,04,630.5246.235.957.82%12.76%14.68%0.7424.84
Aurobindo Pharma97,756.7126.382.586.34%9.25%11.76%1.1512.48
Lupin92,144.5417.653.8313.91%23.76%24.88%1.429.85
Glenmark Pharma70,608.3839.286.729.03%28.08%32.7%1.2320.09

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Torrent Pharmaceuticals Company Background

ISIN
INE685A01028
Sector Market Cap
₹ 176,300.50 Cr

Torrent Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations in India and internationally. The Company is focused on various therapeutic segments, such as cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI), vitamins minerals nutrients (VMN), anti-diabetes (AD), pain management, gynecology, and dermatology. Its pediatric product brands include Tedibar, Atogla, Spoo and B4 Nappi. Its Anti-diabetic products include Gliclazide 80 mg, Tablets, Gliclazide 30 mg, Tablets, Glimepiride 1, 2, 3, 4 mg, Tablets, and others. Its dermatologic therapy products include Macrotor, Ahaglow S Facewash, Fungicide Lotion, Hairjoy 2%, New Dewsoft Cream, Lookbrite 20GMS, Cortaz NC, Dermanex, and others. Its manufacturing facilities are located in the states of Gujarat, Himachal Pradesh, Madhya Pradesh, Andhra Pradesh and Sikkim.

Torrent Pharmaceuticals Financial Highlights

  • Revenue: Torrent Pharmaceuticals reported revenue of ₹13,886.00 crore in FY26 vs ₹11,539.00 crore in FY25. It showed an increase of 20.34% on a yearly basis.
  • Operating Profit: Torrent Pharmaceuticals reported an operating profit of ₹2,872.00 crore in FY26 vs ₹2,673.00 crore in FY25. It showed an increase of 7.44% on a year-on-year basis.
  • Net Profit: Torrent Pharmaceuticals reported a net profit of ₹2,138.00 crore in FY26 vs ₹1,911.00 crore in FY25. It showed an increase of 11.88% on a yearly basis.

Torrent Pharmaceuticals Quarterly Result Highlights

  • Torrent Pharmaceuticals reported revenue of ₹4,969.00 crore in Sep 2026, compared with ₹4,909.00 crore in Jun 2026, representing an increase of 1.22% on a quarter-on-quarter (QoQ) basis.
  • Torrent Pharmaceuticals reported an operating profit of ₹737.00 crore in Sep 2026, compared with ₹733.00 crore in Jun 2026, representing an increase of 0.55% on a quarter-on-quarter (QoQ) basis.
  • Torrent Pharmaceuticals reported a profit of ₹534.00 crore in Sep 2026, compared with ₹566.00 crore in Jun 2026, reflecting a decrease of 5.65% on a QoQ basis.
  • The earnings per share (EPS) of Torrent Pharmaceuticals stood at ₹63.92 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
60.78%
FII
17.22%
Other DII
4.64%
Retail and other
8.54%
Mutual funds
8.82%
Foreign Institutional Investor (FII)
FII shareholding by period
Mar 202616.18%
Jun 202615.44%
Jul 202617.97%
Sep 202617.22%

Torrent Pharmaceuticals Investment Returns

1 day
-0.60%
1 week
+2.84%
1 month
-1.30%
1 year
+31.75%
3 years
+140.26%
5 years
+234.12%

Torrent Pharmaceuticals Share Price History

Torrent Pharmaceuticals share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
05 Nov 26
₹4,753.40 / ₹4,710.00
-0.60%
04 Nov 26
₹4,649.90 / ₹4,738.50
+1.90%
03 Nov 26
₹4,595.00 / ₹4,650.00
+1.20%
02 Nov 26
₹4,636.50 / ₹4,595.00
-0.40%
Show more

Torrent Pharmaceuticals Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹13,979.73₹11,516.09₹10,727.84₹9,620.15
Other Income-₹93.58₹23.27₹57.91₹45.14
Total Revenue₹13,886.15₹11,539.36₹10,785.75₹9,665.29
Total Expenses₹10,925.21₹8,842.34₹8,522.02₹7,818.13
Profit Before Tax₹2,872.19₹2,672.81₹2,352.11₹1,847.16
Tax₹734.01₹761.56₹695.73₹601.93
Profit After Tax₹2,138.18₹1,911.25₹1,656.38₹1,245.23
EPS - Basic₹63.92₹56.47₹48.94₹36.79
EPS - Diluted₹63.92₹56.47₹48.94₹36.79

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹2,872.19₹2,672.81₹2,352.11₹1,847.16
Income before WC changes₹4,173.60₹3,668.86₹3,346.10₹2,784.40
Change in Assets-₹328.20-₹296.98₹22.11-₹53.29
Change in Liabilities-₹13.77-₹183.95₹395.97₹35.09
Change in WC-₹341.97-₹480.93₹418.08-₹18.20
Cash flow from Operations₹3,022.71₹2,585.11₹3,266.08₹2,368.13
Cash flow from Investing-₹12,712.41-₹540.05-₹167.90-₹2,415.31
Cash flow from Financing₹10,150.60-₹2,297.99-₹2,779.64₹77.36
Total Cash Flow₹460.90-₹252.93₹318.54₹30.18
Cash (Start of the year)₹573.48₹835.14₹508.53₹398.40
Cash (End of the year)₹1,117.20₹573.48₹835.14₹508.53

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹34,920.07₹9,367.17₹9,449.10₹9,698.13
Current Assets₹9,391.89₹5,622.57₹5,611.48₹5,313.72
Total Assets₹44,311.96₹14,989.74₹15,060.58₹15,011.85
Current Liabilities₹8,343.33₹4,717.19₹5,425.25₹5,447.30
Net Current Asset₹1,048.56₹905.38₹186.23-₹133.58
Non-Current Liabilities₹18,383.80₹2,681.86₹2,779.18₹3,366.48
Equity Capital₹17,584.83₹7,590.69₹6,856.15₹6,198.07
Total Equity & Liabilities₹44,311.96₹14,989.74₹15,060.58₹15,011.85

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹10,712.00₹9,682.44₹8,532.90₹7,695.20
Other Income₹17.92₹31.50₹91.36₹81.88
Total Revenue₹10,729.92₹9,713.94₹8,624.26₹7,777.08
Total Expenses₹7,763.29₹7,079.55₹6,707.69₹6,200.06
Profit Before Tax₹2,896.61₹2,610.18₹1,916.57₹1,577.02
Tax₹705.02₹722.12₹559.49₹525.63
Profit After Tax₹2,191.59₹1,888.06₹1,357.08₹1,051.39
EPS - Basic₹64.75₹55.79₹40.10₹31.07
EPS - Diluted₹64.75₹55.79₹40.10₹31.07

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹2,896.61₹2,610.18₹1,916.57₹1,577.02
Income before WC changes₹3,912.76₹3,579.68₹2,874.18₹2,567.51
Change in Assets-₹466.77-₹638.12₹212.68-₹51.24
Change in Liabilities₹0.78₹123.05₹130.92₹21.60
Change in WC-₹465.99-₹515.07₹343.60-₹29.64
Cash flow from Operations₹2,730.83₹2,574.50₹2,893.10₹2,265.41
Cash flow from Investing-₹12,990.20-₹470.09-₹296.07-₹2,384.07
Cash flow from Financing₹10,225.23-₹2,104.46-₹2,577.57₹80.74
Total Cash Flow-₹34.14-₹0.05₹19.46-₹37.92
Cash (Start of the year)₹104.81₹104.86₹85.40₹65.00
Cash (End of the year)₹70.67₹104.81₹104.86₹85.40

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹20,922.49₹8,492.96₹8,635.53₹8,944.85
Current Assets₹4,891.04₹4,348.80₹3,741.06₹3,927.08
Total Assets₹25,813.53₹12,841.76₹12,376.59₹12,871.93
Current Liabilities₹4,588.83₹2,979.63₹2,988.60₹3,409.15
Net Current Asset₹302.21₹1,369.17₹752.46₹517.93
Non-Current Liabilities₹12,772.53₹2,269.63₹2,559.23₹3,006.82
Equity Capital₹8,452.17₹7,592.50₹6,828.76₹6,455.96
Total Equity & Liabilities₹25,813.53₹12,841.76₹12,376.59₹12,871.93
* All values are in INR Crore
Torrent Pharmaceuticals market depth
Bid quantityBid priceAsk priceAsk quantity
0047101
0000
0000
0000
0000
Total bid quantity0
Total ask quantity1
Torrent Pharmaceuticals technical summary
Bearish indicators4
Neutral indicators3
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
55.34
Neutral
ATR (14)
116.04
Neutral
STOCH(9,6)
100
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
29.26
Bearish
UO(9)
61.35
Neutral
ROC(12)
3.94
Bullish
WillR(14)
0
Bearish
Period
Simple value
Exponential vaue
5D
4635.38
4653.16
10D
4604.86
4628.83
20D
4609.96
4648.1
50D
4790.42
4727.97
100D
4808.53
4722.7
Volume trend — traded volume by day
5 Nov5L
4 Nov5L
3 Nov2L
2 Nov3L
30 Oct4L
Average4L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Torrent Pharmaceuticals
Pharmaceuticals
Add Stock
Add Another

Torrent Pharmaceuticals Returns Calculator

Ex-date: 29 May 2026
Ex-date: 18 Feb 2026

Torrent Pharmaceuticals Latest News

1 week ago
Torrent Pharma Q2 earnings: Profit declines 10% YoY to ₹534 crore, US revenue surges 24%
1 week ago
Q2 results, Oct 23: Infosys, Adani Power, JSW Steel, Tata Motors, BPCL, CG Power, Torrent Pharma, Shriram Finance, others to post earnings
3 weeks ago
Dr Reddy’s, Torrent Pharma, Zydus Life: Pharma stocks to post resilient growth in Q2 earnings despite pricing headwinds
1 month ago
Sun Pharma, Mankind Pharma, Wockhardt, other pharma stocks surge up to 6%, Nifty Pharma up 1.5%; key things to know
2 months ago
Sun Pharma, Laurus Labs, Mankind Pharma, others drag Nifty Pharma down 1.6%; here’s what investors should know
3 months ago
Stocks to watch, July 31: Swiggy, Tata Steel, Astra Microwave, Mazagon Dock, Navin Fluorine, Torrent Pharma, Maruti Suzuki, Sun Pharma
3 months ago
Q3 Results: Torrent Pharma, GMR Airports, Info Edge, Fortis, Ola Electric, KFin Tech, FirstCry, others to release earnings on Feb 13; check list
3 months ago
Torrent Pharma, Mankind, Cipla, others lift Nifty Pharma 1.8%; why are pharma stocks rising in weak market?
3 months ago
Torrent Pharma shares fall over 2% after pharma major recalls select batches of Semalix injection
3 months ago
Stocks to watch, July 10: L&T Finance, Dixon Tech, TCS, IT stocks, BoM, Indian Bank, Torrent Pharma, SAIL
Showing news item 1 of 10

Top Gainers

UNOMINDA Share Price
₹1335.00
+138.1 (+11.54%)
ASHOKLEY Share Price
₹170.21
+16.18 (+10.5%)
DEVYANI Share Price
₹129.21
+10.53 (+8.87%)
SOBHA Share Price
₹1291.90
+103.9 (+8.75%)
FIVESTAR Share Price
₹429.85
+32.7 (+8.23%)
See more

Top Losers

PIIND Share Price
₹1770.00
-417 (-19.07%)
CUMMINSIND Share Price
₹4058.90
-666.8 (-14.11%)
APTUS Share Price
₹179.93
-26.35 (-12.77%)
GMMPFAUDLR Share Price
₹1194.20
-126 (-9.54%)
CHENNPETRO Share Price
₹1418.50
-148.4 (-9.47%)
See more

Torrent Pharmaceuticals Share Price FAQs

Please be aware that Torrent Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.